1Tominaga S.A putative protein of a growth specific cDNA fromBALB/c-3T3cells is highly similar to the extracellular portion ofmouse interleukin 1receptor[J].FEBS Lett,1989,258:301.
2Xu D,Chan WL,Leung BP,et al.Selective expression of a stablecell surface molecule on type 2but not type 1helper T cells[J].JExp Med,1998,287:787.
3Tago K,Noda T,Hayakawa M,et al.Tissue distribution and sub-cellular localization of a variant form of the human ST2geneproduct,ST2V[J].Biochem Biophys Res Commun,2001,285:1377.
4Iwahana H,Hayakawa M,Kuroia K,et al,Molecular cloning ofthe chicken ST2gene and a novel vaiant form of the ST2geneproduct,ST2LV[J].Biochim Biophs Acta,2004,1681:1.
5Schmitz J,Owyang A,Oldham E,et al.IL-33,an interleukin-1-like cytokine that signals via the IL-1receptor-related proteinST2and induces T helper type 2-associated cytokines[J].Immu-nity,2005,23:479.
6Baekkevold ES,Roussigne M,Yamanaka T,et al.Molecular char-acterization of NF-HEV,a nuclear factor preferentially expressedin human high endothelial venules[J].Am J Path,2003,163:69.
8Mueller T,Dieplinger B,Gegenhuber A,et al.Increased plasmaconcentrations of soluble ST2are predictive for 1-year mortalityin patients wigh acute destabilized heart failure[J].Clin Chem,2008,54;752.
9James L Januzzi,W Frank Peacock,Alan S Maisel,et al.Meas-urement of the Interleukin Family Member ST2in Patients WithAcute Dyspnea[J].J Am Coll Cardio1,20o7,50:607.
10Sabatine MS.Complementary roles for biomarkers of biome-chanical strain st2and n-term inal prohormone b-type matri-uretic peptide in patients with st-elevation myocardinal infarc-tion[J].Circulation,2008,117(15):1936.
二级参考文献24
1Daniels LB,Maizel AS.Natriuretic peptides[J].J Am Coll Cardiol2007,50(25):2357-2368.
2Januzzi JL,Camargu CA.The N-terminal Pro-BNP investigation of dys pnea in the emergency department(PRIDE)study[J].Am J Cardiol,200595(8):948-954.
3Moe GW,Howlett J.N-terminal pro-B-type natriuretic peptide testin improves the management of patients with suspected acute heart failure primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study[J].Circulation,2007,115(24):3103-3110.
4Januzzi JL,van Kimmenade R.NT-proBNP testing for diagnosis an short-term prognosis in acute destabilized heart failure:an internationa pooled analysis of 1256 patients.The International Collaborative of NTproBNP Study[J].Eur Heart J,2006,27(3):330-337.
5Berdague P,Caffin PY.Use of N-terminal prohormone brain natriureti peptide assay for etiologic diagnosis of acute dyspnea in elderly patient[J].Am Heart J,2006,151(3):690-698.
6Baggish AL,van Kimmenade R.The differential diagnosis of an elevated amino-terminal pro-b-type natriuretyic peptide level[J].Am J Cardio2008,98(3A):43A-48A.
7Cleland JGF,Cohtta AP,Clark AL,et al.Clinical trials update from the American college of cardiology[J].Eur J Heart Fail,2009,11(6):622-630.
8Pfisterer M,Buser P.BNP-guided vs symptom-guided heart failure ther apy:the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure(time-chf)randomized trial[J].JA M A,2009,301(4):383-392.
9Latini R,Masson S.Prognostic value of very low plasma concentration of troponin T in patients with stable chronic heart failure[J].Circula.tion,2007,116(11):1242-1249.
10Rehman SU,Mueller T.Characteristica of the novel interhukin family biomarker st2 in patients with acute heart failure[J].J Am Coil Cardiol,2008,52(18):1458-1465.
